Filing Flows › Comparisons › USPH vs WGS
U S Physical Therapy vs GeneDx Holdings: USPH and WGS compared
U S Physical Therapy is the larger company: $223M of revenue in its latest quarter (Q3 2026) against $114M for GeneDx Holdings (Q2 2026). U S Physical Therapy is growing faster (+13% against +11% a year earlier). U S Physical Therapy is more profitable, with an operating margin of 11.3% against -15.3%.
Where the money goes: USPH and WGS
U S Physical Therapy (USPH) · Q3 2026
U S Physical Therapy, Q3 2026: revenue $223M (+13% year over year), operating margin 11.3%, net earnings $11.0M, operating cash flow $25.7M. The chart follows the revenue to costs, profit and cash.
GeneDx Holdings (WGS) · Q2 2026
GeneDx Holdings, Q2 2026: revenue $114M (+11% year over year), operating margin -15.3%, net loss $17.7M, operating cash flow −$29.0M. The chart follows the revenue to costs, profit and cash.
| U S Physical Therapy (USPH) | GeneDx Holdings (WGS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $223M | $114M |
| Revenue growth, Y/Y | +13% | +11% |
| Gross margin | 19.3% | — |
| Operating margin | 11.3% | -15.3% |
| Net earnings | $11.0M | −$17.7M |
| Net margin | 5.0% | -15.5% |
| Operating cash flow | $25.7M | −$29.0M |
| Free cash flow | $20.7M | — |
| Market value | $1.3B | $2.0B |
| P/E | 40.4× | — |
| Analysts’ mean target | $97.83 | $93.50 |
Where the revenue comes from
U S Physical Therapy
- Net Patient Revenue: $161M (72%)
- Other Revenue: $36.4M (16%)
- Hospital Affiliation Revenue: $25.0M (11%)
GeneDx Holdings
- Diagnostic Test: $112M (98%)
- Other revenue: $2.6M (2%)
Questions
Which is bigger, U S Physical Therapy or GeneDx Holdings?
U S Physical Therapy is the larger company: $223M of revenue in its latest quarter (Q3 2026) against $114M for GeneDx Holdings (Q2 2026).
Is U S Physical Therapy or GeneDx Holdings growing faster?
U S Physical Therapy is growing faster (+13% against +11% a year earlier).
Which is more profitable, U S Physical Therapy or GeneDx Holdings?
U S Physical Therapy is more profitable, with an operating margin of 11.3% against -15.3%.
More: U S Physical Therapy earnings · how U S Physical Therapy makes money · GeneDx Holdings earnings · how GeneDx Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 3, 2026). Fiscal quarters can end on different dates. Not investment advice.